Bal Pharma Limited (BALPHARMA) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.129x

Based on the latest financial reports, Bal Pharma Limited (BALPHARMA) has a cash flow conversion efficiency ratio of 0.129x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs101.16 Million ≈ $1.09 Million USD) by net assets (Rs783.30 Million ≈ $8.47 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See BALPHARMA defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Bal Pharma Limited - Cash Flow Conversion Efficiency Trend (2006–2026)

This chart illustrates how Bal Pharma Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Bal Pharma Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Bal Pharma Limited ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Viver Incorporadora e Construtora S.A SA:VIVR3	1.272x
Raptis Group Ltd AU:RPG	0.037x
KineMaster Corporation KQ:139670	0.039x
De.Mem Ltd AU:DEM	0.064x
Aegis Brands Inc TO:AEG	0.013x
Ohmyhome Limited Ordinary Shares NASDAQ:OMH	-0.507x
MOGU Inc NYSE:MOGU	-0.035x
Gale Pacific Ltd AU:GAP	0.027x

Annual Cash Flow Conversion Efficiency for Bal Pharma Limited (2006–2026)

The table below shows the annual cash flow conversion efficiency of Bal Pharma Limited from 2006 to 2026. For the full company profile with market capitalisation and key ratios, see BALPHARMA market cap overview.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2026-03-31	Rs822.52 Million ≈ $8.90 Million	Rs144.72 Million ≈ $1.57 Million	0.176x	+221.79%
2025-03-31	Rs774.04 Million ≈ $8.37 Million	Rs42.32 Million ≈ $457.70K	0.055x	-83.39%
2024-03-31	Rs692.61 Million ≈ $7.49 Million	Rs228.06 Million ≈ $2.47 Million	0.329x	+1237.80%
2023-03-31	Rs637.02 Million ≈ $6.89 Million	Rs-18.43 Million ≈ $-199.37K	-0.029x	-106.11%
2022-03-31	Rs584.92 Million ≈ $6.33 Million	Rs277.08 Million ≈ $3.00 Million	0.474x	+16.04%
2021-03-31	Rs533.54 Million ≈ $5.77 Million	Rs217.81 Million ≈ $2.36 Million	0.408x	-19.88%
2020-03-31	Rs453.38 Million ≈ $4.90 Million	Rs231.01 Million ≈ $2.50 Million	0.510x	+295.55%
2019-03-31	Rs602.21 Million ≈ $6.51 Million	Rs77.58 Million ≈ $838.95K	0.129x	+1663.52%
2018-03-31	Rs602.01 Million ≈ $6.51 Million	Rs-4.96 Million ≈ $-53.64K	-0.008x	-108.44%
2017-03-31	Rs600.31 Million ≈ $6.49 Million	Rs58.58 Million ≈ $633.56K	0.098x	+127.59%
2016-03-31	Rs547.22 Million ≈ $5.92 Million	Rs-193.53 Million ≈ $-2.09 Million	-0.354x	-234.25%
2015-03-31	Rs551.68 Million ≈ $5.97 Million	Rs145.33 Million ≈ $1.57 Million	0.263x	-0.97%
2014-03-31	Rs500.50 Million ≈ $5.41 Million	Rs133.13 Million ≈ $1.44 Million	0.266x	-27.36%
2013-03-31	Rs446.18 Million ≈ $4.83 Million	Rs163.39 Million ≈ $1.77 Million	0.366x	+14.07%
2012-03-31	Rs400.56 Million ≈ $4.33 Million	Rs128.58 Million ≈ $1.39 Million	0.321x	+151.97%
2011-03-31	Rs361.75 Million ≈ $3.91 Million	Rs46.09 Million ≈ $498.42K	0.127x	+187.92%
2010-03-31	Rs357.62 Million ≈ $3.87 Million	Rs-51.82 Million ≈ $-560.40K	-0.145x	-142.27%
2009-03-31	Rs372.35 Million ≈ $4.03 Million	Rs127.64 Million ≈ $1.38 Million	0.343x	+32.33%
2008-03-31	Rs350.32 Million ≈ $3.79 Million	Rs90.75 Million ≈ $981.39K	0.259x	+67.86%
2007-03-31	Rs334.02 Million ≈ $3.61 Million	Rs51.55 Million ≈ $557.46K	0.154x	+183.48%
2006-03-31	Rs323.02 Million ≈ $3.49 Million	Rs-59.71 Million ≈ $-645.75K	-0.185x	--

About Bal Pharma Limited

NSE:BALPHARMA India Drug Manufacturers - Specialty & Generic

Market Cap

$15.12 Million

Rs1.40 Billion INR

Market Cap Rank

#25973 Global

#1436 in India

Share Price

Rs87.79

Change (1 day)

-0.20%

52-Week Range

Rs60.42 - Rs103.59

All Time High

Rs151.23